IL15 and neoplasm: demonstrated expression of a membrane bound form of IL-15 (mbIL-15) in human PB-NK cells enhanced anti-tumor killing against hematologic malignancies and solid tumors by augmenting NK cell survival and expansion in vitro and in vivo without the need of additional exogenous cytokines (87).